Matches in Wikidata for { <http://www.wikidata.org/entity/Q91652264> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91652264 description "article scientifique publié en 2018" @default.
- Q91652264 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91652264 description "scientific article published on 20 September 2018" @default.
- Q91652264 description "wetenschappelijk artikel" @default.
- Q91652264 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91652264 name "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 name "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 type Item @default.
- Q91652264 label "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 label "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 prefLabel "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 prefLabel "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 P1433 Q91652264-9DE622B3-D4EC-4AD9-89D1-9CA8E91A32B3 @default.
- Q91652264 P1476 Q91652264-7696A3AA-8234-479A-9948-61C1F09B2D52 @default.
- Q91652264 P2093 Q91652264-69FBADA4-3F89-4FE3-8FD2-71DA70DA277B @default.
- Q91652264 P2093 Q91652264-7A62ADB4-C782-45C2-B6DE-C5E4EC8C8123 @default.
- Q91652264 P2093 Q91652264-96D87151-1FDD-4E17-BE2E-6E45D2133EC1 @default.
- Q91652264 P2093 Q91652264-B5578ABD-A606-46DE-ABA6-0E7107140DB6 @default.
- Q91652264 P2093 Q91652264-BE4D47CE-DB5B-4260-A483-2A917A84B1E9 @default.
- Q91652264 P2093 Q91652264-BEEDDB5B-94C4-4C63-88AE-69E17B3DDB47 @default.
- Q91652264 P2093 Q91652264-FD19EF03-0891-4860-A106-4B31EFFB4501 @default.
- Q91652264 P304 Q91652264-278C6969-F739-4945-87E4-3F5C80DDD9DC @default.
- Q91652264 P31 Q91652264-0634C8C8-8990-45E0-A8EA-C6AC7B0E30D4 @default.
- Q91652264 P356 Q91652264-02ED6157-B92C-4659-AD4E-6054803A8A1C @default.
- Q91652264 P433 Q91652264-109B2E32-457A-492A-A315-5FB2712C2C88 @default.
- Q91652264 P478 Q91652264-B9CE2EF1-E3EB-474C-B474-12DCFAAF6B58 @default.
- Q91652264 P577 Q91652264-0C2CBFD3-E6C6-4802-A4C9-9D0B666D13A1 @default.
- Q91652264 P698 Q91652264-AC9E7E65-EF3A-4815-B531-FCDEB54143CD @default.
- Q91652264 P921 Q91652264-E1457970-7E9C-4D97-AAA7-547BCE89BD4D @default.
- Q91652264 P356 J.BBRC.2018.09.061 @default.
- Q91652264 P698 30243721 @default.
- Q91652264 P1433 Q864228 @default.
- Q91652264 P1476 "Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling" @default.
- Q91652264 P2093 "Dejun Yang" @default.
- Q91652264 P2093 "Hongbing Fu" @default.
- Q91652264 P2093 "Jiapeng Xu" @default.
- Q91652264 P2093 "Qingping Cai" @default.
- Q91652264 P2093 "Yu Zhang" @default.
- Q91652264 P2093 "Yuan Tang" @default.
- Q91652264 P2093 "Zunqi Hu" @default.
- Q91652264 P304 "215-221" @default.
- Q91652264 P31 Q13442814 @default.
- Q91652264 P356 "10.1016/J.BBRC.2018.09.061" @default.
- Q91652264 P433 "1" @default.
- Q91652264 P478 "505" @default.
- Q91652264 P577 "2018-09-20T00:00:00Z" @default.
- Q91652264 P698 "30243721" @default.
- Q91652264 P921 Q212961 @default.